The effects of the insect growth regulator pyriproxyfen were evaluated on the mortality, fecundity, longevity, and predation capability of 2 species of copepods, Mesocyclops pehpeiensis Hu and Megacyclops viridis (Jurine), under laboratory conditions. Pyriproxyfen showed no significant effects on either the development or reproduction of M. pehpeiensis at 0.1 ppm, which is a 10-fold greater concentration than the reported effective dosage for controlling mosquito larvae (0.01 ppm). In contrast, the development of M. viridis was impaired by pyriproxyfen at 0.1 ppm. An 80% reduction in nauplius survivorship was observed in the experimental (treated) group compared with the control group. Although the application of pyriproxyfen caused high mortality in the nauplius stage of this species, the pyriproxyfen-treated group developed faster, killed more mosquito larvae, yielded more eggs per oviposition event, and survived longer than the control group. These results indicate that pyriproxyfen caused mortality in the earlier stages of this sensitive species but that the surviving individuals were those that were selected for significantly faster development, better predation ability, and greater longevity during their reproductive stage. Therefore, under natural conditions, pyriproxyfen would cause modifications in the characteristics of a copepod population rather than its complete loss. Our results suggest that the combined application of copepods and pyriproxyfen to control Aedes populations is feasible. However, repeated application of pyriproxyfen may cause changes in copepod populations and communities in the affected ecosystem.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 21 • No. 4